(MIRM) Mirum Pharmaceuticals - Performance 39.8% in 12m
MIRM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
73.99%
#4 in Peer-Group
Rel. Strength
82.94%
#1308 in Stock-Universe
Total Return 12m
39.83%
#26 in Peer-Group
Total Return 5y
182.81%
#6 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 39.7 |
| High / Low | USD |
|---|---|
| 52 Week High | 53.46 USD |
| 52 Week Low | 37.37 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 85.09 |
| Buy/Sell Signal +-5 | 0.31 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MIRM (39.8%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: MIRM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MIRM
| Total Return (including Dividends) | MIRM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 8.67% | 3.15% | 4.01% |
| 3 Months | 33.05% | 17.08% | 17.14% |
| 12 Months | 39.83% | -11.14% | 13.46% |
| 5 Years | 182.81% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | MIRM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 44.5% | 52.1% | 90.3% |
| 3 Months | 93.2% | 79.4% | 97.5% |
| 12 Months | 62.8% | -87.4% | 46.4% |
| 5 Years | 85.8% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th68.00 | 5.35% | 4.48% |
| 3 Month | %th65.00 | 13.64% | 13.58% |
| 12 Month | %th87.50 | 57.36% | 23.24% |
| 5 Years | %th98.00 | 262.38% | 32.94% |
FAQs
Does Mirum Pharmaceuticals (MIRM) outperform the market?
Yes,
over the last 12 months MIRM made 39.83%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months MIRM made 33.05%, while XBI made 17.08%.
Performance Comparison MIRM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MIRM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.9% | 4.7% | 11.8% | 26% |
| US NASDAQ 100 | QQQ | 4% | 4.5% | 9.8% | 27% |
| German DAX 40 | DAX | 3.5% | 7.5% | -0.3% | 10% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.7% | 4.1% | 7.3% | 21% |
| Hongkong Hang Seng | HSI | 3% | 5.8% | -10.2% | 5% |
| India NIFTY 50 | INDA | 5.2% | 9.5% | 11.3% | 43% |
| Brasil Bovespa | EWZ | 8.1% | 9.3% | -3.3% | 38% |
MIRM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.3% | 7% | 8.5% | 16% |
| Consumer Discretionary | XLY | 3% | 5.3% | 19.5% | 22% |
| Consumer Staples | XLP | 5.9% | 8.8% | 12.7% | 32% |
| Energy | XLE | 0.9% | 4.5% | 19.3% | 38% |
| Financial | XLF | 5.3% | 6% | 9.5% | 14% |
| Health Care | XLV | 3.7% | 8.6% | 23.3% | 47% |
| Industrial | XLI | 3.5% | 4.2% | 5.9% | 16% |
| Materials | XLB | 3.2% | 4.2% | 11.2% | 36% |
| Real Estate | XLRE | 4.1% | 8.8% | 13.3% | 32% |
| Technology | XLK | 4% | 2% | 6.7% | 29% |
| Utilities | XLU | 3.8% | 6.1% | 7.8% | 20% |
| Aerospace & Defense | XAR | 3.2% | 1.8% | -8.2% | -9% |
| Biotech | XBI | 0.2% | 5.5% | 22% | 51% |
| Homebuilder | XHB | 0.8% | -0.1% | 18.4% | 41% |
| Retail | XRT | 3.9% | 5.4% | 16.6% | 33% |
MIRM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.3% | 5.37% | 25.7% | 44% |
| Natural Gas | UNG | 5.6% | 15.1% | 37.8% | 42% |
| Gold | GLD | 3.8% | 8.4% | -6.1% | 1% |
| Silver | SLV | -0.5% | 2.4% | -10.3% | 18% |
| Copper | CPER | -6.5% | -6.3% | -7.8% | 16% |
MIRM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.8% | 8.7% | 17.1% | 44% |
| iShares High Yield Corp. Bond | HYG | 4.4% | 7.5% | 14.8% | 31% |